NCT00859560已完成不适用
Retrospective Survey of Bone Fracture in Post-Menopausal Breast Cancer Patients With Arimidex 1 mg as Adjuvant Therapy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 2,205
- 主要终点
- Bone fracture incidence
研究概览
简要总结
The retrospective survey is to investigate the incidence of bone fracture in post-menopausal breast cancer patients with Arimidex 1mg, who were previously registered for the clinical experience investigation.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Post-menopausal breast cancer patients treated with Arimidex 1mg at the time of previously conducted clinical experience investigation.
排除标准
- 未提供
结局指标
主要结局
Bone fracture incidence
时间窗: Time since starting Arimidex
次要结局
- Bone density measurement(Time since starting Arimidex)
- Survival(Time since starting Arimidex)
研究者
相似试验
已完成
不适用
The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal WomenOsteoporosis, PostmenopausalNCT01381588GlaxoSmithKline1,136
已完成
不适用
A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast CancerPostmenopausal Bone LossBreast CancerNCT00399321University of Michigan Rogel Cancer Center9
招募中
不适用
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase InhibitorsBreast CancerNCT05590949Memorial Sloan Kettering Cancer Center100
尚未招募
Unknown
A study of Bone Health on Aromatase InhibitorsCTRI/2023/06/054340Tata Memorial Hospital
已完成
不适用
Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in PakistanPostmenopausal OsteoporosisNCT02422069Hoffmann-La Roche624